Showing results (141-150 of 229) with videos related to

Sort By:
Pageof 23
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|May 28, 2008
Simple ultrasound-based rules for the diagnosis of ovarian cancerD Timmerman, A C Testa, T Bourne, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 14, 2005
What is the role of dose-dense therapy?M E L van der Burg, A van der Gaast, I Vergote, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|May 23, 2006
New models to predict depth of infiltration in endometrial carcinoma based on transvaginal sonographyF De Smet, J De Brabanter, T Van den Bosch, et al.
British Journal of Cancer|July 28, 2012
Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patientsU Wagner, C Marth, R Largillier, et al.
British Journal of Cancer|January 14, 2012
CA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: experience of the GCIG CALYPSO trialJ Alexandre, C Brown, D Coeffic, et al.
Cancer Research|June 11, 1998
Genomic changes in endometrial polyps associated with tamoxifen show no evidence for its action as an external carcinogenP Dal Cin, D Timmerman, I Van den Berghe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 18, 2013
Breast cancer phenotype, nodal status and palpability may be useful in the detection of overdiagnosed screening-detected breast cancersO Brouckaert, A Schoneveld, C Truyers, et al.
Gynecologic Oncology|January 26, 2020
Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-DS Timmerman, A S Van Rompuy, T Van Gorp, et al.
Gynecologic Oncology|July 8, 2011
Intraperitoneal treatment with the trifunctional bispecific antibody Catumaxomab in patients with platinum-resistant epithelial ovarian cancer: a phase IIa study of the AGO Study GroupK Baumann, J Pfisterer, P Wimberger, et al.
British Journal of Cancer|April 24, 2025
Single-cell profiling in ovarian germ cell and sex cord-stromal tumoursT Laga, A S Van Rompuy, P Busschaert, et al.
Pageof 23